All News

New branded Rxs, OTCs, home health care items, health & beauty, etc.

The International Pharmaceutical Federation addressed progress in identifying and dealing with issues related to ersatz (or replacement) drug products.

New Jersey woman sues hospital for drug error that led state to take away newborn daughter.

Pharmacists as licensed prescribers.

In its coverage of incidents of Tylenol tamperingin the 1980s, Drug Topics urged pharmacists not to panic.

The Centers for Medicare and Medicaid Services moves fowarded with implementing new tamper-restantant prescription pad rules.

An effort coordinated by the National Heart, Lung, and Blood Institute, the National Asthma Education and Prevention Program has created a comprehensive update to their asthma guidelines. The new guide emphasizes the importance of keeping the condition under control and highlights the fact that part of the process means appropriate use of both quick-relief and long-term control medications.

Not only are there effective antidiabetes treatments on the market, but drugs in development promise to expand patient options even further.

FDA seeks comments on behind-the-counter drugs

The Novartis FluGram program allows people to offer the flu vaccine as a gift that can be redeemed at pharmacies.

Medco and UnitedHealth announce details of their 2008 Medicare Part D prescription plans.

Walgreens launches catalogue, Web site for AARP members

FDA makes changes to levothyroxine potency specifications

Erbitux approved as single agent for metastatic colorectal cancer

CMS has issued clarification for mass immunizers and centralized billers.

FFF Enterprises launches MyFluVaccine provider network

Hypermune products now latex-free

DEA proposes self-certification fee for sellers of scheduled listed chemical products

URAC names first companies to earn PBM accreditations

SmartCare offers flu immunizations

Clarithromycin oral suspension approved for Ranbaxy Pharmaceuticals

A black box warning for nephrogenic systemic fibrosis has been added to the prescribing information of gadolinium-based contrast agents.

Beginning in January, CMS will require NPI numbers for Medicare.

Medicare Part D plans raised drug prices during plan year, according to a study by Consumer Reports.

Medical board survey shows increased prosecution of overprescribers and need for addiction education

Public support exists for access to experimental drugs

FDA approves Verigene test for warfarin (Coumadin) metabolism

Drug mix-ups occur frequently in Pennsylvania

Lamisil oral granules are approved by the FDA for tinea capitis

Docetaxel approved for squamous cell head and neck cancer